Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation

被引:1162
作者
Kavsak, P
Rasmussen, RK
Causing, CG
Bonni, S
Zhu, HT
Thomsen, GH
Wrana, JL
机构
[1] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
[2] Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5S 1A8, Canada
[3] SUNY Stony Brook, Dept Biochem & Cell Biol, Ctr Dev Genet, Stony Brook, NY 11794 USA
关键词
D O I
10.1016/S1097-2765(00)00134-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Ubiquitin-mediated proteolysis regulates the activity of diverse receptor systems. Here, we identify Smurf2, a C2-WW-HECT domain ubiquitin ligase and show that Smurf2 associates constitutively with Smad7. Smurf2 is nuclear, but binding to Smad7 induces export and recruitment to the activated TGF beta receptor, where it causes degradation of receptors and Smad7 via proteasomal and lysosomal pathways. IFN gamma, which stimulates expression of Smad7, induces Smad7-Smurf2 complex formation and increases TGF beta receptor turnover, which is stabilized by blocking Smad7 or Smurf2 expression. Furthermore, Smad7 mutants that interfere with recruitment of Smurf2 to the receptors are compromised in their inhibitory activity. These studies thus define Smad7 as an adaptor in an E3 ubiquitin-ligase complex that targets the TGF beta receptor for degradation.
引用
收藏
页码:1365 / 1375
页数:11
相关论文
共 34 条
  • [1] Induction of inhibitory Smad6 and Smad7 mRNA by TGF-β family members
    Afrakhte, M
    Morén, A
    Jossan, S
    Itoh, S
    Westermark, B
    Heldin, CH
    Heldin, NE
    ten Dijke, P
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 249 (02) : 505 - 511
  • [2] Differential requirement for type I and type II transforming growth factor β receptor kinase activity in ligand-mediated receptor endocytosis
    Anders, RA
    Dore, JE
    Arline, SL
    Garamszegi, N
    Leof, EB
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (36) : 23118 - 23125
  • [3] Bitzer M, 2000, GENE DEV, V14, P187
  • [4] Ubiquitin and the control of protein fate in the secretory and endocytic pathways
    Bonifacino, JS
    Weissman, AM
    [J]. ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1998, 14 : 19 - 57
  • [5] RETRACTED: SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53 (Retracted Article)
    Buschmann, T
    Fuchs, SY
    Lee, CG
    Pan, ZQ
    Ronai, Z
    [J]. CELL, 2000, 101 (07) : 753 - 762
  • [6] Rapid flux in transforming growth factor-beta receptors on bone cells
    Centrella, M
    Ji, CH
    Casinghino, S
    McCarthy, TL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (31) : 18616 - 18622
  • [7] THE WW DOMAIN OF YES-ASSOCIATED PROTEIN BINDS A PROLINE-RICH LIGAND THAT DIFFERS FROM THE CONSENSUS ESTABLISHED FOR SRC HOMOLOGY 3-BINDING MODULES
    CHEN, HI
    SUDOL, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) : 7819 - 7823
  • [8] Smads:: Transcriptional activators of TGF-β responses
    Derynck, R
    Zhang, Y
    Feng, XH
    [J]. CELL, 1998, 95 (06) : 737 - 740
  • [9] Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor
    Hata, A
    Lagna, G
    Massagué, J
    Hemmati-Brivanlou, A
    [J]. GENES & DEVELOPMENT, 1998, 12 (02) : 186 - 197
  • [10] The MAD-related protein Smad7 associates with the TGF beta receptor and functions as an antagonist of TGF beta signaling
    Hayashi, H
    Abdollah, S
    Qiu, YB
    Cai, JX
    Xu, YY
    Grinnell, BW
    Richardson, MA
    Topper, JN
    Gimbrone, MA
    Wrana, JL
    Falb, D
    [J]. CELL, 1997, 89 (07) : 1165 - 1173